Jeff Aronin (born December 8, 1967) is a biopharmaceutical executive and civic leader. He is chairman, CEO and founder of Marathon Pharmaceuticals LLC, a privately owned company headquartered in Northbrook, Illinois. He is also chairman, CEO and founder of Paragon Pharmaceutical Capital, LLC, an investment firm that backs healthcare companies.
Prior to operating Marathon and Paragon, Aronin founded Ovation Pharmaceuticals LLC in 2000 and served as its chairman and CEO for nine years. On February 9, 2009, it was announced that H. Lundbeck A/S, a Danish pharmaceutical company, had purchased Ovation for $900 million. Chicago Mayor Rahm Emanuel appointed Aronin to the board of directors of World Business Chicago and co-chair of ChicagoNEXT. Aronin is also co-chair MATTER, a start-up center in Chicago for next-generation healthcare technology companies that opened in February 2015. He also serves on the board of trustees of Discover Financial Services and on the board of trustees of the Museum of Science and Industry.
- "How Paragon's Jeffrey Aronin built two companies out of niche drugs". Voices. Sun-Times Media, LLC. Retrieved 14 July 2014.
- Kapos, Shia (9 March 2010). "Jeff Aronin back in business with new pharma company". Crain's Chicago Business. Retrieved 14 July 2014.
- Graham, Meg. "Jeff Aronin of Marathon Pharmaceuticals on life after a $900M exit". Chicagotribune.com. The Chicago Tribune. Retrieved 3 December 2015.
- "Board of Directors". World Business Chicago. Retrieved 14 July 2014.
- "Leadership". World Business Chicago. Retrieved 14 July 2014.
- Pletz, John (11 February 2014). "The formation of Matter, Chicago's new health-tech incubator". Crain's Chicago Business. Retrieved 14 July 2014.
- "Governor Quinn Announces MATTER, a New Healthcare Technology Startup Hub". MATTER. Retrieved 14 July 2014.
- "Board of Directors". Discover. Retrieved 14 July 2014.
- "Museum of Science and Industry Leadership". Museum of Science and Industry. Retrieved 14 July 2014.